Calcitonin Gene-Related Peptide
PreclinicalPeptide
Calcitonin Gene-Related Peptide is one of 17 small molecule programs targeting Migraine Without Aura. It is currently in Preclinical.
3
Indications
7
Total Trials
0
Active Trials
16
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
11 competitors in Migraine Without Aura
#DrugCompanyPhaseTrials
1Marinol
Jazz PharmaceuticalsApproved
Rozerem
TakedaApproved
Inderal
WWyeth-Lederle Vaccines
Approved
Vyepti
LundbeckPreclinical
Corlanor
AmgenPreclinical
Adempas
BayerPreclinical
Viagra
VViatris Specialty LLC
Preclinical
Levcromakalim
DDanish Headache Center
Preclinical
Sumatriptan Succinate
GSKPreclinical
Calcitonin Gene-Related Peptide
DDanish Headache Center
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Headache3 trials
Migraine2 trials
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Peptide[2]
- Highest Phase
- Preclinical[1]
- Company
- DDanish Headache Center